Invesco’s Apogee Therapeutics APGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.26M Sell
38,763
-31,924
-45% -$2.32M ﹤0.01% 2342
2025
Q4
$5.34M Buy
70,687
+41,549
+143% +$2.62M ﹤0.01% 2219
2025
Q3
$1.16M Buy
29,138
+2,272
+8% +$86.8K ﹤0.01% 2865
2025
Q2
$1.17M Buy
26,866
+2,556
+11% +$97.2K ﹤0.01% 2783
2025
Q1
$908K Buy
24,310
+3,054
+14% +$118K ﹤0.01% 2876
2024
Q4
$963K Sell
21,256
-110,910
-84% -$5.66M ﹤0.01% 2934
2024
Q3
$7.76M Buy
132,166
+111,783
+548% +$5.36M ﹤0.01% 1978
2024
Q2
$802K Sell
20,383
-96,290
-83% -$4.67M ﹤0.01% 3048
2024
Q1
$7.75M Buy
116,673
+105,064
+905% +$4.59M ﹤0.01% 1962
2023
Q4
$324K Buy
11,609
+1,917
+20% +$38.4K ﹤0.01% 3407
2023
Q3
$206K Buy
+9,692
New +$214K ﹤0.01% 3582

Other funds holding APGE